GGT (Gamma-Glutamyl Transferase)

← Back to Lab Reference Library

Category: Liver & Kidney  |  Also known as: Gamma-Glutamyl Transferase, GGTP  |  Sample: Serum (fasting preferred)

1. What This Test Measures

GGT (Gamma-Glutamyl Transferase) is an enzyme expressed on the surface of many cell types, with particularly high concentrations in the hepatocytes and biliary epithelium of the liver, renal tubular cells, pancreatic acinar cells, and intestinal epithelium. Unlike ALT and AST (which are released by hepatocyte injury), GGT is an inducible enzyme: its production is specifically upregulated by alcohol, certain medications, oxidative stress, and biliary disease, even without frank hepatocellular destruction.

GGT plays a central biological role in glutathione metabolism. It catalyzes the extracellular cleavage of gamma-glutamyl bonds from glutathione and related compounds, releasing constituent amino acids that can be transported into cells for intracellular glutathione resynthesis. When the liver is under oxidative stress, GGT activity increases to scavenge available extracellular glutathione and restore intracellular antioxidant capacity. This is why elevated GGT is not simply a marker of liver cell damage but specifically a marker of hepatic oxidative stress and glutathione depletion.

GGT is the most sensitive liver enzyme test for detecting alcohol use, biliary disease, and enzyme-inducing medications, often rising before ALT and AST in these conditions.

2. Why This Test Matters

• Most sensitive marker for alcohol use: GGT rises even with moderate regular drinking (2 to 3 drinks per day) at levels that leave ALT and AST unchanged. In clinical practice, GGT is the most reliable standard blood test for detecting ongoing alcohol consumption. It normalizes within 4 to 8 weeks of abstinence, making it useful for monitoring alcohol cessation.
• Biliary disease detection: GGT is highly expressed in biliary epithelium and is elevated in cholestatic liver disease including primary biliary cholangitis, primary sclerosing cholangitis, biliary obstruction, and drug-induced cholestasis. GGT elevation alongside elevated ALP distinguishes biliary from bone-sourced ALP, because GGT is elevated in liver and biliary disease but not in bone disease.
• Oxidative stress and glutathione depletion proxy: GGT elevation reflects systemic oxidative stress and hepatic glutathione demand beyond alcohol or biliary causes. Metabolic syndrome, insulin resistance, and NAFLD all produce GGT elevation through hepatic oxidative stress. Elevated GGT in a non-drinker not on enzyme-inducing medications almost always indicates metabolic liver stress.
• Independent cardiovascular mortality predictor: multiple large prospective studies demonstrate that GGT levels within the conventional normal range independently predict cardiovascular mortality, fatal stroke, and all-cause mortality. The EPIC-Norfolk study (over 25,000 participants) found that GGT was a stronger predictor of cardiovascular death than traditional risk factors in some analyses. This cardiovascular connection is thought to reflect GGT's presence on LDL particles within atherosclerotic plaques, where it generates oxidative byproducts that destabilize plaques.
• Enzymatic drug induction marker: GGT is induced by phenytoin, phenobarbital, rifampin, certain statins, and other medications through cytochrome P450 enzyme induction pathways. Elevated GGT with normal ALT and AST in a patient on these medications is often entirely explained by enzymatic induction without hepatocellular injury.

3. Standard Lab Reference Range

Population	Standard Range	Units
Men (adult)	7 to 64	U/L
Women (adult)	5 to 36	U/L

The standard range for GGT is particularly wide and includes significant proportions of subclinical liver disease and alcohol use. Large epidemiological studies demonstrate that cardiovascular and all-cause mortality risk rises continuously from GGT levels above 15 to 25 U/L, well below the laboratory-flagged upper limits.

4. Optimal Functional Medicine Range

GGT Level	Functional Interpretation
Below 15 U/L	Excellent: minimal hepatic oxidative stress or biliary activity
15 to 25 U/L	Optimal: low metabolic risk; acceptable in context of no alcohol or enzyme-inducing medications
25 to 40 U/L	Borderline: evaluate for alcohol, NAFLD, oxidative stress, or medications; cardiovascular risk begins to rise
40 to 64 U/L (W) / 40 to 100 U/L (M)	Elevated: significant hepatic induction or biliary disease; comprehensive evaluation indicated
Above 100 U/L	Markedly elevated: alcohol excess, biliary obstruction, or advanced liver disease; investigate urgently

5. Causes of Elevated GGT

• Alcohol consumption: the most common and most potent driver; GGT rises rapidly with regular alcohol use and is the first liver enzyme to be elevated; even social drinking of 2 to 3 drinks daily elevates GGT before ALT or AST; GGT normalizes within 4 to 8 weeks of abstinence
• Non-alcoholic fatty liver disease (NAFLD): second most common cause; hepatic oxidative stress from fat accumulation and metabolic inflammation induces GGT; elevation in NAFLD is typically 25 to 80 U/L
• Biliary disease: cholestasis from any cause elevates GGT; primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), choledocholithiasis, and biliary strictures produce significant GGT elevation; GGT and ALP elevation together with normal or mildly elevated ALT and AST is the biliary pattern
• Enzyme-inducing medications: phenytoin, phenobarbital, carbamazepine, rifampin, and certain statins induce hepatic cytochrome P450 enzymes alongside GGT through a common nuclear receptor pathway; elevated GGT with normal ALT and AST in patients on these medications is typically enzymatic induction, not hepatocellular injury
• Metabolic syndrome and insulin resistance: independently elevates GGT through hepatic oxidative stress and steatosis
• Pancreatitis: the pancreas has high GGT expression; acute pancreatitis and chronic pancreatitis both elevate GGT
• Thyroid disease: both hyperthyroidism and hypothyroidism can mildly elevate GGT
• Obesity and visceral fat: adipose-tissue-driven oxidative stress and hepatic steatosis raise GGT independent of alcohol

6. GGT, Glutathione, and Oxidative Stress

The functional medicine perspective on GGT goes beyond its role as a liver injury marker. GGT elevation signals that the liver is working harder to regenerate intracellular glutathione in the face of oxidative stress. This has clinical implications:

• Elevated GGT indicates elevated hepatic oxidative burden, which can be addressed through antioxidant support (NAC, lipoic acid, vitamin C, vitamin E) and root-cause reduction of oxidative stressors
• GGT found on LDL particles and within atherosclerotic plaques generates hydrogen peroxide and oxidized lipids that promote plaque vulnerability; this is the mechanism linking GGT to cardiovascular mortality independent of liver disease
• Supporting glutathione synthesis with NAC (N-acetylcysteine), glycine, and glutamine can reduce GGT by restoring intracellular glutathione, reducing the demand for extracellular scavenging

7. How to Improve This Marker

8. The Complete Liver Enzyme Panel: Pattern Interpretation

GGT is particularly valuable in pattern interpretation because it confirms biliary or hepatic origin of ALP elevation and confirms hepatic induction as the driver of AST and ALT elevation:

Pattern	ALT	AST	GGT	ALP	Most Likely Cause
NAFLD	High	Mildly high	Mildly high	Normal	Metabolic liver injury
Alcoholic liver disease	Elevated	Greater than 2x ALT	Markedly high	Normal to mild	Alcohol; GGT most sensitive marker
Biliary obstruction	Mildly elevated	Mildly elevated	High	Markedly high	Choledocholithiasis, cholangiocarcinoma, PBC
Drug-induced cholestasis	Mildly elevated	Mildly elevated	Markedly high	High	Enzyme-inducing medications (phenytoin, statins)
Bone source	Normal	Normal	Normal	Elevated	Bone disease; GGT normal rules out liver source of ALP

9. Related Lab Tests

10. When Testing Is Recommended

• Standard annual metabolic panel; GGT should always be part of a complete liver enzyme assessment alongside ALT, AST, and ALP
• Alcohol use evaluation; GGT is the most sensitive standard blood test for ongoing alcohol consumption
• Distinguishing liver from bone source of elevated ALP; normal GGT with elevated ALP confirms bone origin
• Metabolic syndrome and NAFLD screening; GGT is an early marker of hepatic oxidative stress and steatosis
• Patients on enzyme-inducing medications (phenytoin, phenobarbital, rifampin) to monitor hepatic induction versus true injury
• Cardiovascular risk stratification; GGT adds independent predictive value for cardiovascular mortality
• Monitoring hepatic response to antioxidant interventions, alcohol cessation, and NAFLD treatment

11. Clinical Perspective

12. Frequently Asked Questions